Skip to content
Buy This GLP
← Research
Evidence

AI Support Agent and Semaglutide Adherence at a Digital Clinic: 16,556 Patients

Raw six-month adherence rose after an AI support agent launched, while the adjusted model linked that period with higher odds of attrition.

Editorial profile: Neil SandersBuy This GLP Editorial Team6 min read
Adherence before and after an AI launchraw comparison47.3% → 53.2%higher unadjusted adherenceadjusted modelOR 1.178higher adjusted attrition oddsFactors associated with attrition:heavy month-1 tracking (OR 15.8) · pauses (2.5) · cost (2.5)The study measured fulfilled medication orders.

Research on how long people stay on a GLP-1 uses several measures of persistence. An Australian service examined fulfilled semaglutide orders before and after it launched an AI support agent [1].

Two comparisons from the same records

The study used records for 16,556 adults. Six-month adherence was 53.2% after launch and 47.3% before launch in the unadjusted comparison [1].

The postlaunch period was associated with higher odds of attrition after adjustment for measured factors. The odds ratio was 1.178 (95% CI 1.052 to 1.318). A matched analysis also found higher odds of attrition after launch.

What the study can tell us about support

A separate study of digital engagement and persistence tracked patients in a French early-access program. Both studies examined patterns in engagement without assigning patients to use the digital tools.

The Australian study counted fulfilled orders as its adherence measure. Its comparison cannot isolate the effect of the support agent from other changes over time. Some authors were affiliated with Eucalyptus Health and Amigo AI.

Frequently asked

Did the AI support agent improve adherence?
The unadjusted and adjusted comparisons differed. The study design cannot isolate what changed because of the agent.

Sources

  1. [1] Talay L, Xu C, Alderete J, Hom J, Tan M, Ahuja N (2026). AI Patient Support and 6-Month Medication Adherence in a Digital Obesity Program: A Retrospective Analysis Diabetes, Obesity & Metabolism. PMID 42575845

Where to get it

Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

Open the price desk →

More in Evidence